Table 6. Demographic information of study population used for determination of specificity.
| Characteristic | Group | |||||
|---|---|---|---|---|---|---|
| HIV | HCV | Malaria | Dengue | Asthma | LF | |
| Origin | USA | USA | Vietnam | Vietnam | USA | Sri Lanka (8) and Tahiti (2) |
| No. of patients | 25 | 25 | 25 | 25 | 25 | 10 |
| Age, median (Min-Max) | n.a. | n.a. | 22 (18–40) | 26 (4–67) | 46(17–91) | 33 (13–48) |
| Gender, n (%) | ||||||
| Male | n.a. | n.a. | 24 (96) | 10 (40) | 11 (44) | 6 (60) |
| Female | n.a. | n.a. | 1 (4) | 15 (60) | 14 (56) | 3 (30) |
| Unknown | n.a. | n.a. | 0 (0) | 0 (0) | 0 (0) | 1 (10) |
| Source1 | MC | MC | DLS | DLS | BR | FR3 |
1 MC: Mayo Clinic; DLS: Discovery Life Sciences; BR: Bioreclamation; FR3: Filariasis Research Reagent Resource Center
Abbreviations: LF: Lymphatic Filariasis (Wuchereria bancrofti); n.a.: not available